148 related articles for article (PubMed ID: 37879580)
21. Intercellular Communication Reveals Therapeutic Potential of Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer.
Liu Y; Fang Y; Bao L; Wu F; Wang S; Hao S
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291687
[TBL] [Abstract][Full Text] [Related]
22. TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer.
Zhang R; Shen Y; Zhang Q; Feng X; Liu X; Huo X; Sun J; Hao J
Cell Death Dis; 2023 Dec; 14(12):850. PubMed ID: 38123542
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment.
Tsai TH; Yang CC; Kou TC; Yang CE; Dai JZ; Chen CL; Lin CW
J Cell Physiol; 2021 Jun; 236(6):4669-4680. PubMed ID: 33421130
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer.
Kim S; Choi I; Han IH; Bae H
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555393
[TBL] [Abstract][Full Text] [Related]
25. Hydroxypropyl-β-cyclodextrin inhibits the development of triple negative breast cancer by enhancing antitumor immunity.
Zhu M; Zhao Q; Zhang W; Xu H; Zhang B; Zhang S; Duan Y; Liao C; Yang X; Chen Y
Int Immunopharmacol; 2023 Dec; 125(Pt A):111168. PubMed ID: 37939513
[TBL] [Abstract][Full Text] [Related]
26. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer.
Liubomirski Y; Lerrer S; Meshel T; Morein D; Rubinstein-Achiasaf L; Sprinzak D; Wiemann S; Körner C; Ehrlich M; Ben-Baruch A
Front Immunol; 2019; 10():804. PubMed ID: 31105691
[TBL] [Abstract][Full Text] [Related]
27. BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway.
Lin L; Luo X; Wang L; Xu F; He Y; Wang Q; Yuan C; Xu J; Yan L; Hao H
Int Immunopharmacol; 2020 Aug; 85():106625. PubMed ID: 32485356
[TBL] [Abstract][Full Text] [Related]
28. A specific RAGE-binding peptide inhibits triple negative breast cancer growth through blocking of Erk1/2/NF-κB pathway.
Dai X; Hou Y; Deng T; Lin G; Cao Y; Yu G; Wei W; Zheng Q; Huang L; Ma S
Eur J Pharmacol; 2023 Sep; 954():175861. PubMed ID: 37380046
[TBL] [Abstract][Full Text] [Related]
29. Eugenol modulates the NOD1-NF-κB signaling pathway
Shi X; Zhang W; Bao X; Liu X; Yang M; Yin C
Front Endocrinol (Lausanne); 2023; 14():1136067. PubMed ID: 36923216
[TBL] [Abstract][Full Text] [Related]
30. SCEL regulates switches between pro-survival and apoptosis of the TNF-α/TNFR1/NF-κB/c-FLIP axis to control lung colonization of triple negative breast cancer.
Chan SH; Kuo WH; Wang LH
J Biomed Sci; 2023 Nov; 30(1):93. PubMed ID: 38037106
[TBL] [Abstract][Full Text] [Related]
31. AXL antibody and AXL-ADC mediate antitumor efficacy via targeting AXL in tumor-intrinsic epithelial-mesenchymal transition and tumor-associated M2-like macrophage.
Pei JP; Wang Y; Ma LP; Wang X; Liu L; Zhang Y; Jin R; Ren ZQ; Deng Y; Shen JK; Meng T; Yu K
Acta Pharmacol Sin; 2023 Jun; 44(6):1290-1303. PubMed ID: 36650292
[TBL] [Abstract][Full Text] [Related]
32. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-α stimulation by inhibiting Notch1-Jagged1/NF-κB(p65) signaling.
Chen H; Han X; Zhang Y; Wang K; Liu D; Hu Z; Wang J
Phytomedicine; 2024 Jan; 123():154928. PubMed ID: 38043386
[TBL] [Abstract][Full Text] [Related]
33. Activation of GPER suppresses epithelial mesenchymal transition of triple negative breast cancer cells via NF-κB signals.
Chen ZJ; Wei W; Jiang GM; Liu H; Wei WD; Yang X; Wu YM; Liu H; Wong CK; Du J; Wang HS
Mol Oncol; 2016 Jun; 10(6):775-88. PubMed ID: 26842883
[TBL] [Abstract][Full Text] [Related]
34. Phenanthroindolizidine Alkaloids Isolated from
Reimche I; Yu H; Ariantari NP; Liu Z; Merkens K; Rotfuß S; Peter K; Jungwirth U; Bauer N; Kiefer F; Neudörfl JM; Schmalz HG; Proksch P; Teusch N
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142230
[TBL] [Abstract][Full Text] [Related]
35. Inhibited Expression of NLRP12 Promotes the Development of Triple-Negative Breast Cancer by Activating the NF-κB Pathway.
Kuang W; Gu Q; Zhou Y; Xiao X; He D; Deng Q
Cell Biochem Biophys; 2023 Dec; 81(4):727-735. PubMed ID: 37658975
[TBL] [Abstract][Full Text] [Related]
36. Photoimmunotherapy with cetuximab-conjugated gold nanorods reduces drug resistance in triple negative breast cancer spheroids with enhanced infiltration of tumor-associated macrophages.
Emami F; Pathak S; Nguyen TT; Shrestha P; Maharjan S; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Jan; 329():645-664. PubMed ID: 33022330
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
38. COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk.
Chen X; Ma C; Li Y; Liang Y; Chen T; Han D; Luo D; Zhang N; Zhao W; Wang L; Yang Q
Oncogene; 2024 Jun; 43(23):1742-1756. PubMed ID: 38609499
[TBL] [Abstract][Full Text] [Related]
39. Combined MEK inhibition and tumor-associated macrophages depletion suppresses tumor growth in a triple-negative breast cancer mouse model.
Zhang Q; Le K; Xu M; Zhou J; Xiao Y; Yang W; Jiang Y; Xi Z; Huang T
Int Immunopharmacol; 2019 Nov; 76():105864. PubMed ID: 31480004
[TBL] [Abstract][Full Text] [Related]
40. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
